A well-optimized clinical supply chain is critical to the success of clinical trials. From ensuring investigational products reach sites on time to mitigating risks and maintaining compliance, effective supply chain management plays a pivotal role in trial execution. Syner-G BioPharma Group’s latest white paper explores key components of supply chain strategy, best practices for resource optimization, and approaches to navigating regulatory challenges. Download the white paper to gain expert insights on how to streamline your clinical supply operations and enhance trial efficiency: https://bit.ly/41zVuwV #ClinicalTrials #ClinicalSupplyChain #Biopharma #RegulatoryCompliance
Syner-G BioPharma Group
制药业
Framingham,MA 8,701 位关注者
To enable our clients to achieve success and enhance human health while inspiring our colleagues to excel! #weinspire
关于我们
Syner-G BioPharma Group provides in-depth expertise across the three key elements of Chemistry, Manufacturing, and Controls (CMC): Regulatory Services, Technical Development, and Quality/IT. We call this CMC 360?. We also provide medical writing services, with expertise in authoring a variety of regulatory documents across a wide range of therapeutic areas and in all phases of development. Our regulatory affairs services include the development and implementation of global regulatory strategic plans, regulatory agency meeting support, and electronic submissions to regulatory authorities around the world. We have the skill set and experience to guide your prime asset through any development challenges and along the ever-changing maze of regulatory filing pathways, to a position of full compliance, and high quality. Our expertise spans small molecules, peptides, oligonucleotides, biologics, monoclonal antibodies, antibody-drug conjugates, and cell and gene therapy products.
- 网站
-
https://www.synergbiopharma.com/
Syner-G BioPharma Group的外部链接
- 所属行业
- 制药业
- 规模
- 201-500 人
- 总部
- Framingham,MA
- 类型
- 私人持股
- 领域
- cGMP Solutions、Regulatory Science for Pharm Development、CMC Formulation Development、Post-Approval CMC、Medical Writing Services、Biologics、Cell and Gene、Project Management、Regulatory Services和CMC
地点
Syner-G BioPharma Group员工
动态
-
Marie Monaghan’s curiosity for life sciences began in high school, sparking a lifelong passion for developing treatments that improve lives. As a woman in biopharma, she believes that empathy, collaboration, and diverse leadership drive real innovation in the industry. For Marie, the best part of working at Syner-G BioPharma Group and Sequoia Biotech Consulting is the camaraderie—being surrounded by a team of compassionate and brilliant professionals. Inspired by her mother’s unwavering work ethic, she’s committed to making an impact every day. Learn more about Marie’s journey: https://bit.ly/3QFYTVY #MovingForwardTogether #AccelerateAction #WomensHistoryMonth
-
-
Meet Sujata Kulkarni, Manager of Regulatory Affairs (CMC) at Syner-G BioPharma Group. Sujata’s passion for biotechnology and commitment to advancing healthcare have shaped her career in biopharma. As a woman in the industry, she takes pride in contributing to global health and being part of a growing community of women breaking barriers. She values Syner-G’s supportive culture, where flexibility and recognition fuel both personal and professional growth. Inspired by resilience, determination, and small acts of kindness, Sujata believes even the smallest contributions can create meaningful change. Read more about Sujata’s journey: https://bit.ly/3Xm42WS #WomensHistoryMonth #WomenInSTEM #AccelerateAction #MovingForwardTogether
-
-
Big news at Syner-G BioPharma Group & Sequoia Biotech Consulting! We’re thrilled to welcome Christopher Erickson as our new Chief Operating Officer. With over 25 years of experience in pharmaceutical services, Chris has a proven track record of scaling global operations, enhancing commercial strategies, and driving customer-centric growth. Most recently, Chris was the Chief Commercial Officer at Cytel, where he led exponential growth in operations, consulting, and software. His leadership will be instrumental as we continue to expand and strengthen our integrated life sciences services. Welcome to the team, Chris! Full release: https://bit.ly/4iqHzQv #LifeSciences #Leadership #Biotech #Pharma
-
-
This Women's History Month, we're spotlighting the talented women at Syner-G BioPharma Group and Sequoia Biotech Consulting who are shaping the future of biopharma. From regulatory strategy to product development, their expertise and dedication drive innovation and improve patient outcomes. Throughout March, we’ll be sharing their stories, insights, and the impact they’re making in the industry. Stay tuned as we recognize and celebrate the women who inspire us every day. #WomensHistoryMonth #WomenInBiopharma #WomenInSTEM #OneTeam #WeInspire
-
-
Syner-G BioPharma Group and Sequoia Biotech Consulting will attend DCAT (Drug, Chemical & Associated Technologies Association) Week 2025 in New York City! Our team looks forward to engaging with partners and industry leaders to discuss regulatory strategy, product development, functional outsourcing, medical writing, and quality & compliance solutions. Let’s make the most of this week of networking and innovation. Will you be there? Let’s connect. To schedule a meeting, please fill out our contact form: https://lnkd.in/dUq7tAwF #DCATWeek #BioPharma #PharmaceuticalManufacturing #RegulatoryExcellence
-
-
Syner-G BioPharma Group is heading to BioAsia 2025 in Hyderabad! Join us at the Hyderabad International Convention Centre on February 25-26 as we connect with global leaders driving innovation in life sciences. Our Syner-G India team—Tom Thomas Puthiaparampil, PhD, Sudha Gopinath, and Rehana Begum—will be on-site, ready to discuss how we support biopharma companies in navigating product development, regulatory strategy, and beyond. Looking to connect? Reach out to us: ?? Phone/WhatsApp: +91 98459 11557 Learn more about the event: https://bit.ly/4i0mo7M #BioAsia2025 #LifeSciences #Biopharma #RegulatoryExcellence
-
-
The 2025 ISPE-CaSA Technology Conference is almost here! On February 25th, the combined Syner-G BioPharma Group and Sequoia Biotech Consulting team will be at Table #326 in Raleigh, ready to discuss how we help biopharma innovators navigate regulatory strategy, medical writing, and program execution. Whether you’re advancing a novel therapy or optimizing your development processes, our experts are here to support you. Stop by our table, ask questions, and let’s explore how we can help accelerate your success. #ISPECaSA #Biopharma #RegulatoryStrategy #MedicalWriting
-
-
Computational Fluid Dynamics (CFD) is transforming pharmaceutical manufacturing by providing deeper insights into process development, equipment design, and regulatory compliance. By simulating complex fluid behaviors, heat transfer, and chemical reactions, CFD allows manufacturers to optimize processes, enhance efficiency, and reduce costs—all while maintaining product quality. Our recent edition of Innovations in Biopharma the impact of CFD on manufacturing, from identifying critical process parameters to streamlining regulatory submissions. As the industry evolves, leveraging CFD will be key to staying ahead. At Syner-G BioPharma Group, we help companies integrate advanced modeling techniques to improve process performance and navigate regulatory challenges. Learn more about how CFD can optimize your manufacturing processes. #PharmaceuticalManufacturing #CFD #Biopharma #RegulatoryCompliance
-
We’re excited to share that Syner-G BioPharma Group has received an Honorable Mention in both the Virtual Event of the Year and Employee Events categories for Ragan Communications and PR Daily's Video, Visual & Virtual Awards. These recognitions reflect our ongoing commitment to cultivating a culture of connection, well-being, and impact. Our Making an Impact philanthropic initiatives support the many ways our team goes beyond their daily work to support causes that matter throughout the year. In addition, focusing on events and programming during Mental Health Awareness Month in 2024 emphasized the importance of prioritizing mental health, creating space for reflection, and encouraging open conversations across our team. The 2024 Walk to Well-Being event brought us together in a shared commitment to wellness, reinforcing the power of movement and community. At Syner-G, these programs are more than events—they reflect our values and the culture we continue to build. https://bit.ly/3QczRxq #OneTeam #WeInspire
-